We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Industry

DiagnoCure Acquires Samba Technologies

In a move to insure its future growth, DiagnoCure has acquired the assets, customer lists, and intellectual property of Samba Technologies SARL More...
30 Nov -0001

Abbott and Wyeth to Develop Test for Sirolimus

A collaboration to jointly develop an automated blood test to monitor therapeutic levels of sirolimus, an anti-rejection drug for transplant patients, has been announced by Abbott Laboratories and Wyeth More...
30 Nov -0001

Abbott to Acquire i-STAT for $392 Million

In a move to further enhance the company's position in point-of-care (POC) diagnostics, Abbott Laboratories has agreed to acquire i-STAT Corp. for about U.S.$392 million. More...
30 Nov -0001

Growth Seen for European POC Coagulation Testing

The point-of-care (POC) testing market in Europe will grow from 140 million euros in 2003 to more than 350 million euros in 2009, according to a new analysis from international consultants Frost & Sullivan. More...
30 Nov -0001

MIT Outlicenses Biosensor Technology

New biosensor technology that can be used for extremely rapid testing of analytes, developed by researchers at the Massachusetts Institute of Technology, has been licensed to Innovative Biosensors, Inc. More...
30 Nov -0001

Tests for POC and Homeland Defense

Exclusive rights to market an innovative line of rapid-result blood and urine tests have been granted to QT 5, Inc. (Westlake Village, CA, USA; www.qt5inc.com) by an undisclosed source. More...
30 Nov -0001

BioMosaics Obtains Rights to Liver Cancer Test

A novel diagnostic test for hepatocellular carcinoma (HCC) has been licensed to BioMosaics, Inc. which employs a unique monoclonal antibody to glypican 3 (GPC3), known to have increased expression in HCC and shown to be detectable in tissue specimens and serum. More...
30 Nov -0001
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2024 Globetech Media. All rights reserved.